Familial Hypercholesterolemia Heterozygous
📧 Sign up to get email alerts when something new happens for Familial Hypercholesterolemia Heterozygous.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies [Phase 3]
This trial update reports long-term safety and tolerability data for inclisiran in participants with familial hypercholesterolemia (heterozy…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Randomized, Placebo-Controlled, Double-Blind, Phase 3b Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH [Phase 3]
A Phase 3b randomized, placebo-controlled, double-blind trial of Lerodalcibep in children aged 6-17 with heterozygous familial hypercholeste…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia [Phase 3]
A Phase 3 trial assessing the efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolemia has completed…
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN) [Phase 3]
Phase 3 trial update (ODYSSEY JAPAN) evaluating the efficacy and safety of alirocumab in patients with heterozygous familial hypercholestero…